Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/133826
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Keir, A. | - |
dc.contributor.author | Rumbold, A. | - |
dc.contributor.author | Shepherd, E. | - |
dc.contributor.author | Mcintyre, S. | - |
dc.contributor.author | Groves, C. | - |
dc.contributor.author | Cavallaro, A. | - |
dc.contributor.author | Crowther, C. | - |
dc.contributor.author | Callander, E. | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Australian and New Zealand Journal of Obstetrics and Gynaecology, 2022; 62(1):168-171 | - |
dc.identifier.issn | 0004-8666 | - |
dc.identifier.issn | 1479-828X | - |
dc.identifier.uri | https://hdl.handle.net/2440/133826 | - |
dc.description | First published: 29 November 2021 | - |
dc.description.abstract | Previous work demonstrated that implementing a quality improvement (QI) program improves the uptake of guideline-recommended antenatal magnesium sulphate, a critical intervention known to reduce cerebral palsy risk. Here we estimate potential cost savings attributable to the improved uptake. By expanding coverage from 63 to 83% of eligible women, we estimated that five children potentially would not have received a diagnosis of cerebral palsy, a potential cost saving of $AU4.8 million in lifetime healthcare costs. Our findings strengthen the case for embedding QI approaches in perinatal care to reduce the incidence of cerebral palsy. | - |
dc.description.statementofresponsibility | Amy Keir, Alice Rumbold, Emily Shepherd, Sarah Mcintyre, Charlotte Groves, Angela Cavallaro, Caroline Crowther, and Emily Callander | - |
dc.language.iso | en | - |
dc.publisher | Wiley | - |
dc.rights | © 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists | - |
dc.source.uri | http://dx.doi.org/10.1111/ajo.13459 | - |
dc.subject | magnesium sulphate | - |
dc.subject | cerebral palsy | - |
dc.subject | quality improvement | - |
dc.subject | cost-benefit analysis | - |
dc.title | Antenatal magnesium sulphate for preventing cerebral palsy: An economic evaluation of the impact of a quality improvement program | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/ajo.13459 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1161379 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1159536 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Keir, A. [0000-0003-1692-5676] | - |
dc.identifier.orcid | Rumbold, A. [0000-0002-4453-9425] | - |
dc.identifier.orcid | Shepherd, E. [0000-0002-9669-788X] | - |
dc.identifier.orcid | Crowther, C. [0000-0002-9079-4451] | - |
Appears in Collections: | Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.